03/29/2024
3:29 PM | TherapeuticsMD (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
3:32 PM | TherapeuticsMD (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
12/07/2023
3:51 PM | TherapeuticsMD (Issuer)
Walker Marlan D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
10:36 AM | TherapeuticsMD (Subject)
Walker Marlan D (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/17/2023
8:27 AM | Rosen David Efraim (Reporting)
Rubric Capital Management LP (Reporting)
TherapeuticsMD (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
8:28 AM | Rubric Capital Management LP (Filed by)
TherapeuticsMD (Subject)
| Form SC 13D/A | |
08/21/2023
3:20 PM | TherapeuticsMD (Issuer)
ZIEGLER JOSEPH (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/21/2023
3:22 PM | TherapeuticsMD (Issuer)
ZIEGLER JOSEPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
4:18 PM | TherapeuticsMD (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
6:30 AM | TherapeuticsMD (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2023
6:30 AM | TherapeuticsMD (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2023
6:15 AM | TherapeuticsMD (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2023
4:27 PM | Collins Cooper C. (Reporting)
TherapeuticsMD (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2023
4:28 PM | Naughton Gail K (Reporting)
TherapeuticsMD (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2023
4:29 PM | TherapeuticsMD (Issuer)
Thompson Tommy G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2023
4:20 PM | TherapeuticsMD (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/06/2023
3:38 PM | TherapeuticsMD (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2023
7:29 AM | Rubric Capital Management LP (Filed by)
TherapeuticsMD (Subject)
| Form SC 13D/A | |
06/29/2023
4:21 PM | Rosen David Efraim (Reporting)
Rubric Capital Management LP (Reporting)
TherapeuticsMD (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
6:00 AM | TherapeuticsMD (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/05/2023
4:26 PM | TherapeuticsMD (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
